159 related articles for article (PubMed ID: 37847024)
1. Adeno-associated virus-vectored erythropoietin gene therapy for anemia in cats with chronic kidney disease.
Vaden SL; Kendall AR; Foster JD; New HL; Eagleson JS; May JL; Traas AM; Wilson MJ; McIntyre BH; Hinderer CJ; Olenick LK; Wilson JM
J Vet Intern Med; 2023; 37(6):2200-2210. PubMed ID: 37847024
[TBL] [Abstract][Full Text] [Related]
2. Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector.
Beall CJ; Phipps AJ; Mathes LE; Stromberg P; Johnson PR
Gene Ther; 2000 Mar; 7(6):534-9. PubMed ID: 10757028
[TBL] [Abstract][Full Text] [Related]
3. A lentivirus-vectored feline erythropoietin gene therapy strategy in tissue culture and rodent models for the potential treatment of chronic renal disease-associated anemia.
Cook SE; Castillo D; Wolf T; Hillman C; Bauer K; Williams S; Murphy BG
Am J Vet Res; 2024 Jun; 85(6):. PubMed ID: 38626794
[TBL] [Abstract][Full Text] [Related]
4. Expression of erythropoietin in cats treated with a recombinant adeno-associated viral vector.
Walker MC; Mandell TC; Crawford PC; Simon GG; Cahill KS; Fernandes PJ; MacLeod JN; Byrne BJ; Levy JK
Am J Vet Res; 2005 Mar; 66(3):450-6. PubMed ID: 15822590
[TBL] [Abstract][Full Text] [Related]
5. Expression, bioactivity, and clinical assessment of recombinant feline erythropoietin.
Randolph JE; Scarlett JM; Stokol T; Saunders KM; MacLeod JN
Am J Vet Res; 2004 Oct; 65(10):1355-66. PubMed ID: 15524322
[TBL] [Abstract][Full Text] [Related]
6. The use of darbepoetin to stimulate erythropoiesis in anemia of chronic kidney disease in cats: 25 cases.
Chalhoub S; Langston CE; Farrelly J
J Vet Intern Med; 2012; 26(2):363-9. PubMed ID: 22296687
[TBL] [Abstract][Full Text] [Related]
7. The Use of Darbepoetin to Stimulate Erythropoiesis in the Treatment of Anemia of Chronic Kidney Disease in Dogs.
Fiocchi EH; Cowgill LD; Brown DC; Markovich JE; Tucker S; Labato MA; Callan MB
J Vet Intern Med; 2017 Mar; 31(2):476-485. PubMed ID: 28256075
[TBL] [Abstract][Full Text] [Related]
8. Quantitative studies of erythropoiesis in the clinically normal, phlebotomized, and feline leukemia virus-infected cat.
Wardrop KJ; Kramer JW; Abkowitz JL; Clemons G; Adamson JW
Am J Vet Res; 1986 Oct; 47(10):2274-7. PubMed ID: 3022625
[TBL] [Abstract][Full Text] [Related]
9. Urinary F
Whitehouse W; Quimby J; Wan S; Monaghan K; Robbins R; Trepanier LA
J Vet Intern Med; 2017 Mar; 31(2):449-456. PubMed ID: 28160524
[TBL] [Abstract][Full Text] [Related]
10. Intra-arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial.
Thomson AL; Berent AC; Weisse C; Langston CE
J Vet Intern Med; 2019 May; 33(3):1353-1361. PubMed ID: 30924554
[TBL] [Abstract][Full Text] [Related]
11. Changes in systolic blood pressure over time in healthy cats and cats with chronic kidney disease.
Bijsmans ES; Jepson RE; Chang YM; Syme HM; Elliott J
J Vet Intern Med; 2015; 29(3):855-61. PubMed ID: 25917326
[TBL] [Abstract][Full Text] [Related]
12. Relationship between indirect blood pressure and various stages of chronic kidney disease in cats.
Hori Y; Heishima Y; Yamashita Y; Isayama N; Kanno N; Nakamura K; Iguchi M; Ibaragi T; Onodera H; Aramaki Y; Hirakawa A; Yamano S; Katagi M; Kitade A; Sawada T
J Vet Med Sci; 2018 Mar; 80(3):447-452. PubMed ID: 29311521
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of feline chronic kidney disease in Portugal: a questionnaire-based study.
Magalhães TR; Lourenço AL; Corbee RJ; Queiroga FL
J Feline Med Surg; 2023 Nov; 25(11):1098612X231206125. PubMed ID: 37987623
[TBL] [Abstract][Full Text] [Related]
14. Update on Medical Management of Clinical Manifestations of Chronic Kidney Disease.
Quimby JM
Vet Clin North Am Small Anim Pract; 2016 Nov; 46(6):1163-81. PubMed ID: 27593576
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous C.E.R.A. for the Maintenance Treatment of Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study.
Warady BA; Meyer Reigner S; Tirodkar C; Drozdz D
Am J Kidney Dis; 2023 Jun; 81(6):684-694.e1. PubMed ID: 36587890
[TBL] [Abstract][Full Text] [Related]
16. Therapeutics of managing reduced red cell mass associated with chronic kidney disease - Is there a case for earlier intervention?
Elliott J
J Vet Pharmacol Ther; 2023 May; 46(3):145-157. PubMed ID: 37036059
[TBL] [Abstract][Full Text] [Related]
17. ISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in Cats.
Taylor SS; Sparkes AH; Briscoe K; Carter J; Sala SC; Jepson RE; Reynolds BS; Scansen BA
J Feline Med Surg; 2017 Mar; 19(3):288-303. PubMed ID: 28245741
[TBL] [Abstract][Full Text] [Related]
18. Anemia of renal disease: what it is, what to do and what's new.
Chalhoub S; Langston C; Eatroff A
J Feline Med Surg; 2011 Sep; 13(9):629-40. PubMed ID: 21872790
[TBL] [Abstract][Full Text] [Related]
19. Anemia Treatment by Erythropoiesis-stimulating Agents during the 6 Months before the Initiation of Hemodialysis: Comparison of Darbepoetin Alfa and Continuous Erythropoietin Receptor Activator.
Yoshida T; Hayashi M
Keio J Med; 2017 Sep; 66(3):44-50. PubMed ID: 27990008
[TBL] [Abstract][Full Text] [Related]
20. Acute-Phase Proteins and Iron Status in Cats with Chronic Kidney Disease.
Javard R; Grimes C; Bau-Gaudreault L; Dunn M
J Vet Intern Med; 2017 Mar; 31(2):457-464. PubMed ID: 28140480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
